Search Results for 'Cirrhosis Liver'

Cirrhosis Liver published presentations and documents on DocSlides.

 Decompensated cirrhosis Clinical Practice Guidelines
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Treatment regimens
Treatment regimens
by natalia-silvester
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
C-SALT Study:
C-SALT Study:
by marina-yarberry
grazoprevir. . + . elbasvir. . in genotype 1 wi...
Treatment regimens
Treatment regimens
by mitsue-stanley
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
No  randomisation
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
Not  randomised Open-label
Not randomised Open-label
by cheryl-pisano
18-70 years. HCV genotype 1 or 3. Naïve or failu...
Simplified HCV Therapy in 2018
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Efficacy and Safety of
Efficacy and Safety of
by olivia-moreira
Efficacy and Safety of Glecaprevir / Pibrentasvi...
INVESTOR FACT SHEET
INVESTOR FACT SHEET
by kittie-lecroy
INVESTOR FACT SHEET October 2011 Lipocine Inc. F...
Mazen Hassanain Portal Hypertension
Mazen Hassanain Portal Hypertension
by escapistlego
Causes. Cirrhosis. Non-cirrhosis. Symptoms. Asympt...
Management of Alcoholic Hepatitis
Management of Alcoholic Hepatitis
by friendma
and Cirrhosis. W. Ray Kim, MD. Gastroenterology an...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
Cirrhosis National Digestive Diseases Information Clea
Cirrhosis National Digestive Diseases Information Clea
by karlyn-bohler
Scar tissue replaces healthy liver tissue and par...
Daclatasvir
Daclatasvir
by tatyana-admore
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
Primary Biliary Cirrhosis Name Change InitiativePart 1Supported by the
Primary Biliary Cirrhosis Name Change InitiativePart 1Supported by the
by mitsue-stanley
said “this couldn’t happen at a better t...
Hepatitis B Case Studies
Hepatitis B Case Studies
by yoshiko-marsland
Nina Kim, MD MSc. Associate Professor of Medicine...
SIRIUS
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
Randomisation
Randomisation
by pamella-moone
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
B.  Taskin, Bern 12.08.2015
B. Taskin, Bern 12.08.2015
by mitsue-stanley
Liver. Imaging Reporting . and. Data System . w...
LIVERFAILURE/CIRRHOSIS/PORTALHYPERTENSION
LIVERFAILURE/CIRRHOSIS/PORTALHYPERTENSION
by trish-goza
ContinuationofMetforminUseAfteraDiagnosisof Cirrho...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
60% of lean body weight = water
60% of lean body weight = water
by danika-pritchard
(2/3) intracellular. . (1/3)ext...
Hepatitis B Case Studies
Hepatitis B Case Studies
by alida-meadow
Nina Kim, MD MSc. Associate Professor of Medicine...
No  randomisation
No randomisation
by pamella-moone
Open-label. 18-70 years. HCV genotype 1. Naïve o...
Gynecomastia
Gynecomastia
by pamella-moone
. Dr. . Ayed. . Alanezi. Senior . spescialist....
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
SOF + RBV
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
Two parallel arms
Two parallel arms
by test
Open label. ≥ . 18 years, . HCV genotype 1 to ...
Sofosbuvir-Velpatasvir  in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
≥ 18 years HCV genotype 1, 2, 4, 5, 6
≥ 18 years HCV genotype 1, 2, 4, 5, 6
by alexa-scheidler
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Hepatocellular carcinoma in West Africa:
Hepatocellular carcinoma in West Africa:
by tatyana-admore
risk factors and pathogenesis. Dr Richard Phillip...
AHCCCS Pharmacy and Therapeutics Committee
AHCCCS Pharmacy and Therapeutics Committee
by debby-jeon
August 16, 2016. 5-17-16 Minutes. Review and vote...
Approach to Ascites Updated by Daniel Kim, 06/2017
Approach to Ascites Updated by Daniel Kim, 06/2017
by tatyana-admore
Objectives. Become familiar with the different et...